We discovered a striking similarity between the TNF and T cell treatments, with nearly 90% of significantly upregulated phosphorylation sites shared between the two conditions in sensitized TRAF2 KO tumor cells (Fig. 1A, B). The gene discussed is TNF; the disease is neoplasm.